Guest Editor(s)

• Prof. Yan-Jiang Wang

  Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.

  Website | E-mail

• Prof. Sheng Chen

  Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

  Website | E-mail

Special Issue Introduction

COVID-19 patients experienced a wide range of symptoms that affect multiple organs and systems of the body. Neurological symptoms were extremely common, appearing in about 80% of patients who had been hospitalized with COVID-19. Furthermore, COVID-19 causes a variety of neurological sequelae in survivors, including cognitive deficits, dizziness, headache, myalgias, hypogeusia, hyposmia, polyneuropathy, myositis, cerebrovascular diseases, encephalitis, and encephalopathy et al. These long-term neurological outcomes dramatically threaten the quality of life in COVID-19 survivors. Recent research advances have identified the fact that even mild COVID-19 may cause irreversible microstructure damage in the brain, suggesting an intimate association between COVID-19 and brain disorders.

With the increasing amount of the population surviving COVID-19, the long-term neurological consequences should be concerned. Therefore, we launched this special issue to collect advances in the neurological consequences of COVID-19.

This special issue will welcome submissions including but not limited to:
● Clinical investigations about the neurological manifestations and/or sequelae of COVID-19
● Clinical investigations about the consequences of COVID-19 in subjects with neurological diseases
● Studies of the mechanism through which COVID-19 can damage the brain
● Preventative measures to reduce the negative implications in the brain associated with COVID-19
● Treatment of neurological disorders caused by COVID-19
● Opinions and Perspectives that focus on the impact of COVID-19 on the brain (This special issue solicits the submission of Opinion and Perspective articles on both animal and human models that provide editorialized analysis related to the scope of “COVID-19 and the brain” by established researchers in this area of expertise)

Keywords

COVID-19, SARS-CoV-2, brain, neurology

Submission Deadline

15 Dec 2022

Submission Information

For Author Instructions, please refer to http://ageneudisjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=and&IssueId=and220630
Submission Deadline: 15 Dec 2022
Contacts: Leila Wang, Assistant Editor, leila@ageneudisjournal.com